Binkui Li

専門分野: Hepatobiliary surgeon
勤務先: 中国, 広州, Sun Yat-sen University Cancer Center (SYSUCC)
中山大学腫瘍防治中心の教授、博士課程指導教官、肝臓外科部長である李斌奎は、外科手術、血管インターベンション治療、分子標的薬治療、免疫療法を組み合わせた肝がんの集学的治療を主導しています。臨床面では、進行肝がんに対するコンバージョンセラピー（当初は切除不能な症例に対する外科手術の機会創出）に注力しており、大腸がんの肝転移手術を含む大腸がんの集学的治療チーム（MDT）の専門メンバーでもあります。
李斌奎（Binkui Li）は、中山大学腫瘍防治中心の専門医であり、教授、博士課程指導教官、肝臓外科部長を務めています。外科手術、血管インターベンション治療、分子標的薬治療、免疫療法を組み合わせた集学的プログラムで肝がんを治療しています。彼の大きな特徴は、進行肝がんに対するコンバージョンセラピー（切除不能な症例を外科手術可能な状態にする治療）のアプローチです。

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

With conversion therapy designed to turn initially unresectable advanced liver cancers into operable cases, Binkui Li focuses on the “multidisciplinary, individualized, systemic treatment” pathway for every patient at Sun Yat-sen University Cancer Center. As Professor, PhD supervisor, and Director of the Liver Surgery Department, he coordinates liver cancer treatment that can include surgery, vascular interventional therapy, targeted therapy, and immunotherapy. His work emphasizes improving curative outcomes and quality of life by tailoring treatment programs to disease stage and biology. Among his core clinical priorities is conversion therapy for advanced liver cancer, which is intended to create surgery opportunities for cases that cannot be resected at presentation. He also participates as an expert member of the Multi-Disciplinary Team (MDT) for colorectal cancer, where he is skilled in surgery of liver metastasis from colorectal cancer. In practice, this means patients are evaluated through a liver-focused surgical lens while systemic options are considered early as part of a single plan.

Education

Education details are not specified in the provided profile materials.

Work experience

Professor and Director of Liver Surgery Department, Sun Yat-sen University Cancer Center (current role).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Binkui Li specializes in multidisciplinary management of liver cancers, integrating operative and non-operative oncologic strategies into one individualized plan.

Conversion therapy for advanced liver cancer to create surgery opportunities for initially unresectable cases.
Surgery of liver metastasis from colorectal cancer as part of colorectal cancer MDT decision-making.
Multidisciplinary treatment of liver cancers including surgery.
Vascular interventional therapy for liver cancer.
Targeted therapy and immunotherapy as components of systemic treatment programs.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Academic output details are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training details are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

For international patients, the advantage of working with a specialist at Sun Yat-sen University Cancer Center is access to coordinated liver cancer decision-making across surgical and systemic options. The clinic’s liver surgery program is structured around multidisciplinary planning, which is especially relevant for advanced-stage disease where timing of conversion therapy and resection matters.